Literature DB >> 30578848

AAAPT Diagnostic Criteria for Acute Sickle Cell Disease Pain.

Joshua J Field1, Samir K Ballas2, Claudia M Campbell3, Lori E Crosby4, Carlton Dampier5, Deepika S Darbari6, Donna K McClish7, Wally R Smith8, William T Zempsky9.   

Abstract

Acute pain episodes are the most common complication in patients with sickle cell disease (SCD). Classically attributed to vaso-occlusion, recent insights suggest that chronic pain may also contribute to the pathogenesis of acute pain episodes, which adds complexity to their diagnosis and management. A taxonomy, or classification system, for acute pain in patients with SCD would aid research efforts and enhance clinical care. To meet this need, the Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks public-private partnership with the U.S. Food and Drug Administration, the American Pain Society, and the American Academy of Pain Medicine formed the Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks-American Pain Society-American Academy of Pain Medicine Pain Taxonomy initiative. One of the goals of this initiative was to develop taxonomies for acute pain disorders, including SCD. To accomplish this, a working group of experts in SCD and pain was convened. Based on available literature and expert opinion, the working group used a 5-dimenional structure (diagnostic criteria, common features, modulating factors, impact/functional consequences, and putative mechanisms) to develop an acute pain taxonomy that is specific to SCD. As part of this, a set of 4 diagnostic criteria, with 2 modifiers to account for the influence of chronic pain, are proposed to define the types of acute pain observed in patients with SCD. PERSPECTIVE: This article presents a taxonomy for acute pain in patients with SCD. This taxonomy could help to standardize definitions of acute pain in clinical studies of patients with SCD.
Copyright © 2018 the American Pain Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Sickle cell disease; pain; taxonomy

Year:  2018        PMID: 30578848     DOI: 10.1016/j.jpain.2018.12.003

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  11 in total

1.  American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain.

Authors:  Amanda M Brandow; C Patrick Carroll; Susan Creary; Ronisha Edwards-Elliott; Jeffrey Glassberg; Robert W Hurley; Abdullah Kutlar; Mohamed Seisa; Jennifer Stinson; John J Strouse; Fouza Yusuf; William Zempsky; Eddy Lang
Journal:  Blood Adv       Date:  2020-06-23

Review 2.  Neuropathic pain in sickle cell disease: measurement and management.

Authors:  Alexander Glaros; Amanda M Brandow
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

3.  Hematopoietic cell transplantation for sickle cell disease: updates and future directions.

Authors:  Lakshmanan Krishnamurti
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

4.  Biopsychosocial Factors Associated with Parenting Stress in Pediatric Sickle Cell Disease.

Authors:  Yelena L Johnson; Kerri Woodward; Carlton Dampier; Lindsey Cohen; Soumitri Sil
Journal:  J Clin Psychol Med Settings       Date:  2022-01-07

5.  Changes in Pain and Psychosocial Functioning and Transition to Chronic Pain in Pediatric Sickle Cell Disease: A Cohort Follow-up Study.

Authors:  Soumitri Sil; Lindsey L Cohen; Nitya Bakshi; Amanda Watt; Morgan Hathaway; Farida Abudulai; Carlton Dampier
Journal:  Clin J Pain       Date:  2020-06       Impact factor: 3.442

6.  Improving self-management in adolescents with sickle cell disease.

Authors:  Lori E Crosby; Anna Hood; Katherine Kidwell; Cara Nwankwo; James Peugh; Heather Strong; Charles Quinn; Maria T Britto
Journal:  Pediatr Blood Cancer       Date:  2020-07-22       Impact factor: 3.167

7.  Medical marijuana certification for patients with sickle cell disease: a report of a single center experience.

Authors:  Susanna A Curtis; Dana Lew; Jonathan Spodick; Jeanne E Hendrickson; Caterina P Minniti; John D Roberts
Journal:  Blood Adv       Date:  2020-08-25

Review 8.  Moving Toward a Multimodal Analgesic Regimen for Acute Sickle Cell Pain with Non-Opioid Analgesic Adjuncts: A Narrative Review.

Authors:  Martha O Kenney; Wally R Smith
Journal:  J Pain Res       Date:  2022-03-31       Impact factor: 3.133

9.  Implementation of Individualized Pain Care Plans Decreases Length of Stay and Hospital Admission Rates for High Utilizing Adults with Sickle Cell Disease.

Authors:  Jena L Welch-Coltrane; Anthony A Wachnik; Meredith C B Adams; Cherie R Avants; Howard A Blumstein; Amber K Brooks; Andrew M Farland; Joshua B Johnson; Manoj Pariyadath; Erik C Summers; Robert W Hurley
Journal:  Pain Med       Date:  2021-08-06       Impact factor: 3.750

10.  Severe Pain Profiles and Associated Sociodemographic and Clinical Characteristics in Individuals With Sickle Cell Disease.

Authors:  Mitchell R Knisely; Paula J Tanabe; Qing Yang; Rita Masese; Meilin Jiang; Nirmish R Shah
Journal:  Clin J Pain       Date:  2021-09-01       Impact factor: 3.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.